Hirsutism Disease

BASICS

DESCRIPTION
Excessive male-pattern hair growth due to increased androgenic hormones
  • Often accompanied by menstrual irregularities
  • Extreme androgenic effects (deep voice, clitorimegaly, balding) is known as virilization
  • System(s) affected: Endocrine/Metabolic, Reproductive
  • Genetics: Multifactorial
  • Incidence/Prevalence in USA: 8% of adult women
  • Predominant age: Postpubertal females
  • Predominant sex: Postpubertal females
SIGNS AND SYMPTOMS
  • Hair thickens and darkens in "male" pattern - beard, moustache, chest hair
  • Usually accompanied by irregular menses and anovulation
  • Usually accompanied by acne
  • May be accompanied by infertility
  • Onset is usually gradual
CAUSES
  • Excessive androgenic effects:
    • Excess hormone production from the ovary or adrenal gland
    • Increased peripheral sensitivity to androgens
    • Decreased sex hormone binding globulin
  • Causes with persistent anovulation:
    • Polycystic ovary disease
    • Hypothyroidism
    • Hyperprolactinemia
  • Ovarian causes:
    • Polycystic ovaries
    • Ovarian tumors
    • Premature ovarian failure
  • Adrenal causes:
    • Tumor (rare)
    • Cushing's (rare)
    • Late onset congenital adrenal hyperplasia
RISK FACTORS
  • Family history
  • Anovulation

DIAGNOSIS

LABORATORY
  • Basic workup - total testosterone, DHEAS, 17-OHP, TSH, prolactin
  • If testosterone > 200, need ovarian tumor workup
  • If DHEAS > 700, need adrenal tumor workup
  • LH/FSH ratio is elevated in 75% of polycystic ovarian disease
  • If testosterone, DHEAS or 17 OHP are elevated, but not in tumor range, treat

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
N/A
SPECIAL TESTS
  • Fasting glucose to insulin ratio to rule out insulin resistance in polycystic ovary syndrome
  • Some do endometrial biopsy if > 35 years old
  • If strong suspicion of Cushing's disease, can do dexamethasone suppression test. Give 1 mg dexamethasone po at PM and draw plasma cortisol at 8:00 am. If cortisol > 5, borderline; if > 10, abnormal.
  • If 17-OHP is 300-800, do ACTH (Cortrosyn) test (ACTH 0.25 mg IV and check 17-OHP at 0 and 1 hour)
  • Some do 3 alpha-androstanediol glucuronide to check for peripheral conversion - but not a good test and doesn't change therapy
  • If DHEAS is high, but not in tumor range, can do low dose dexamethasone test (0.5 mg dexamethasone qid x 5 days, then recheck DHEAS and testosterone - they will decrease if androgens are adrenal and won't if they are ovarian)
IMAGING
  • If testosterone > 200 or DHEAS > 700, need CT of ovaries or adrenals
  • Ultrasound can image polycystic ovaries as a supplement to clinical diagnosis
DIAGNOSTIC PROCEDURES

N/A

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Treatment is slow and often lifelong
  • If patient desires pregnancy, ovulation induction may be necessary
  • Provide contraception as needed
  • Encourage patient to maintain ideal weight
  • Treat accompanying acne
SURGICAL MEASURES

N/A

ACTIVITY

No special activity

DIET

No special diet

PATIENT EDUCATION
  • Hormonal treatment stops further hair growth but will not usually reverse present hair
  • Treatment takes 6-24 months and may be life long
  • Cosmetic measures include - plucking, bleaching, shaving, electrolysis, laser hair removal and cover up cosmetics
  • Electrolysis should be by a licensed professional

FOLLOW UP

PREVENTION/AVOIDANCE
  • Tumor must be ruled out before beginning therapy
  • As hormone balance improves, fertility may increase - provide contraception as needed
  • Patients desiring pregnancy may need fertility intervention such as ovulation induction
  • Women with late onset congenital adrenal hyperplasia may be carriers for the severe early onset childhood disease - counsel
  • Avoid quackery and unlicensed electrolysis
  • Prolonged amenorrhea may, over time, put the patient at risk for endometrial hyperplasia or carcinoma
  • There is an increased incidence of diabetes and insulin resistance in polycystic ovarian disease which can increase risk of heart disease
POSSIBLE COMPLICATIONS
  • Dysfunctional uterine bleeding and anemia
  • Androgenic excess may adversely affect lipid status, cardiac risk and bone density
  • Poor self image/shame
EXPECTED COURSE AND PROGNOSIS
  • Good (with long term therapy) for halting further hair growth
  • Moderate to poor for reversing current hair growth

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Acne
  • Infertility
  • Obesity
  • Hyperinsulinemia
AGE-RELATED FACTORS

Pediatric: N/A
Geriatric: Can occur after menopause if peripheral conversion of estrogen is poor
Others: N/A

PREGNANCY
  • May have related infertility
  • If pregnancy occurs, must discontinue known contraindicated drugs
  • Pregnancy outcome is related to underlying cause of hirsutism
OTHER NOTES

N/A

ABBREVIATIONS

LFTs = liver function tests

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.